Phase 3 TETON study planned in 2021 for Tyvaso in patients with idiopathic pulmonary fibrosis... Dec 09
Cipla Limited today announced that it has launched generic Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis ... Oct 21
-Advertisements-